Brief: 2cureX Redefines Its Go-To-Market Strategy In North Europe

2cureX AB

31/05/2022 07:52

May 31 (Reuters) - 2cureX AB  2CUREX.ST :
    * REDEFINES ITS GO-TO-MARKET STRATEGY IN NORTH EUROPE
    * DISTRIBUTION AGREEMENT WITH YOURRAD AB HAS BEEN TERMINATED
    * NEW DISTRIBUTOR IN FINLAND WILL BE ALGOL DIAGNOSTICS OY
    * COMMERCIAL OPERATIONS IN NORWAY AND SWEDEN WILL BE TAKEN
OVER
DIRECTLY BY 2CUREX
    * ACTIVITIES IN GERMANY WILL INITIALLY AIM AT ENGAGING LOCAL
KEY
OPINION LEADERS THROUGH IGNITE PROGRAM TO SUPPORT INCLUSION OF
TEST IN HOSPITAL GUIDELINES
    * ALGOL AGREEMENT HAS BEEN SIGNED FOR AN INITIAL TERM OF
THREE
YEARS
    * OTHER TERMS OF AGREEMENT HAVE NOT BEEN DISCLOSED
    * SALES IMPACT OF THIS AGREEMENT IS EXPECTED TO SHOW IN 2022

Source text for Eikon:  ID:nMFN9Ctg2P 
Further company coverage:  2CUREX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))